Ethanol extracts of Rehmannia complex (Di Huang) containing no Corni fructus improve early diabetic nephropathy by combining suppression on the ET-ROS axis with modulate hypoglycemic effect in rats

https://doi.org/10.1016/j.jep.2008.05.015Get rights and content

Abstract

Aim

Liuwei Dihuang (Rehmannia complex, RC) decoction, a classic prescription of Traditional Chinese Medicine (TCM), has been used in treating diabetic nephropathy (DN). Among the 6 crude medicines which contains Corni fructus is recognized as the active fraction for its effectiveness. We aimed to investigate, first, if without Corni fructus a modified RC could be still effective, second, if the ethanol extracts could be better than that of water extract and third, the beneficial effect is mainly stemmed from suppressing the endothelin (ET-1) pathway associated with a moderate hypoglycemic effect.

Methods and materials

Diabetes for 8 weeks was induced by a single dose of streptozotocin (STZ, 65 mg/kg, i.p.) in rats and treated with RC extracts in either 95%, 70% ethanol or water separately during 5–8th week. The efficacy of extracts was compared with aminoguanidine (AMG).

Results

An increase in albumin and creatinine in 24 h urine, blood urea nitrogen (BUN) was found in STZ rats. Oxidative stress was found in renal cortex in association with upregulated plasma ET-1 and mRNA of ETA, decreased MMP2,9 (matrix matelloproteinases) and increased hydroxyproline.

Conclusions

The RC without Corni fructus was very effective in alleviating DN and ethanol extracts provided greater effects against water extracts. The efficacy in alleviating DN is attributed to normalizing the activated ET system, oxidative stress and MMP2,9 in combination with a moderate hypoglycemic activity.

Introduction

Diabetic nephropathy (DN) is the most common cause contributing to end-stage renal disease (ESRD) in the United States (Cooper, 2006). Sustained hyperglycemia destroys function and structure in the kidney, leading to albuminuria which in turn further damage the renal tubular structure (Neuhofer and Pittrow, 2006). Glomerular hyperfiltration, enlargement, mesangial expansion, and intertubular fibrosis can be found in diabetic kidney in association with an increase in the extracellular matrix (ECM) (Ohno et al., 2005). These changes are attributed to an excess of formation of AGEs acting as free radicals in a vicious cycle, thus, more ROS are produced resulting in exacerbation of diabetes. A damage to the endothelium of renal vascular system is a causal factor in inducing diabetic nephropathy (DN) that associates with an activated endothelin-1 (ET-1) pathway and an excess of ROS (Neuhofer and Pittrow, 2006). ET-1 as a paracrine plays an important role in the renal physiology, pathology of DN and ESRD (Sorokin and Kohan, 2003). Accompanying sclerosis of glomeruli and degeneration of tubules, an upregulation of renal ET-1 is found in diabetes (Kohan, 2000, Minchenko et al., 2003). Thus, ROS and ET-1 closely linked in diabetic renal lesions (Chen et al., 2000). In addition, an alteration of MMP (matrix matelloproteinases) 2 and 9 contributes to the pathologies of diabetic kidney even in fetuses from diabetic rats (Van- Huyen et al., 2007) and an imbalance in MMPs and TIMPs is found as early changes in diabetic nephropathy (Han et al., 2006). However, changes in MMP2,9 with renal ET-1 system have not been clarified yet.

A Traditional Chinese Medicine (TCM) prescription, Liuwei Dihuang decoction (a six-herb prescription), has been applied in treating diabetes, consisting of 6 crude materials: Rehmannia glutinosa Libosch, Di Huang in Chinese, Alisma orientalis (Sam.) Juzep, the root cortex of Paeonia suffruticosa Andr, and the fungus of Poria cocos (Schw.), Corni fructus and Dioscorea opposite (Thunb.). This prescription is used and modified to contain more plant medicines in treating diabetes in China and Japan (Kitagawa et al., 1971, Kiho et al., 1992, Zhang et al., 1996, Yang et al., 2002, Yokozawa et al., 2004, He et al., 2007). Corni fructus is the most attractive and considered as effective fraction for isolating and testing its in relieving DN (Yamabe et al., 2007a, Yamabe et al., 2007b). We reported the effectiveness of total triperpene acids isolated from Corni fructus is effective in relieving diabetic vasculopathy and retinopathy (Su et al., 2007). On the other hand, DN can be relieved with dried Rehmanniae radix (Di Huang) extract (Yokozawa et al., 2004), however, most ingredients of extracts of Rehmanniae radix are polysaccharides and likely water soluble.

We hypothesized that the benefit of Liuwei Dihuang decoction is multifaceted and the effective fraction of a six crude medicines containing prescription may not be limited to one herb (Corni fructus). Thus, we, first, are intended to test a modified Rehmannia complex containing 4 herbal medicines with no Corni fructus in treating diabetic nephropathy is rats.

Considering the traditional process to prepare the decoction in boiling water, we hypothesized further, the most of active ingredients are lipid soluble in ethanol extracts against water one. Second, if more effectiveness is produced by the ethanol extract against water extracts. Thus, third, its effectiveness mainly comes from normalizing abnormality of the ET-1, ROS and MMP2,9 activity. Considering some of the effects of the Rehmannia complex, beside hypoglycemic activity, may be related to a suppression of the downstream events of AGEs and iNOS (inducible nitric oxide synthase), thus, aminoguanidine (AMG) was chosen as a positive reference medicine in relieving nephropathy in diabetic rats (Wilkinson-Berka et al., 2002).

Section snippets

Plant material

The four crude herbs (Rehmannia glutinosa Libosch, Di Huang in Chinese, Alisma orientalis (Sam.) Juzep, the root cortex of Paeonia suffruticosa Andr, and the fungus of Poria cocos (Schw.) were composed into a modified Rehmannia complex not containing Corni fructus. These were commercial products and purchased from the Nanjing Plant Medicine Co. Ltd., where the sources and species of the medicinal plants were confirmed. Furthermore, the four plant medicines were individually identified by Dr.

Results

Renal hypertrophy was assessed by an increase in the kidney weight (KW) in STZ-treated rats (Table 1) In the untreated diabetic model group the KW was significantly higher and the body weight was significantly reduced (P < 0.05) relative to the control, respectively. Thus, an increase in renal weight may reflect a remodeling of the kidney caused by diabetes. Two ethanol extracts significantly attenuated a loss of body weight and an increment in the kidney, respectively (P < 0.05) but no effect with

Discussion

In the present study, 2-month diabetes by STZ produced an early diabetic nephropathy which manifested increased creatinine, serum BUN, and 24 h urinary albumin. Treatment with extracts of the RC in 95% and 70% ethanol effectively reversed alterations of the redox system, ET-1, and MMPs, and the effects were comparable to those of aminoguanidine.

The RC extracts in 95% and 70% ethanol confer a mild hypoglycemic effect which contributes at least in part to a reversal of diabetic nephropathy. A

Acknowledgements

We are grateful to Prof. Fang-Lu Du (Pharmaceutical department, Hunan college of Traditional Chinese Medicine, Changsha, Hunan province, China) for helpful advices of the extraction. We expressed many thanks to Professor Chris Triggle (Calgary University of Canada) for his critical input during the preparation of this manuscript. We are appreciated to Dr. She-Ban Pu for his kind identification of the four crude medicines. The project was supported by National Natural Science Foundation of

References (51)

  • J. Sottile

    Regulation of angiogenesis by extracellular matrix

    Biochemistry & Biophysics Acta

    (2004)
  • K.I. Sugimoto et al.

    Renal protective effect of YM598, a selective endothelin ETA receptor antagonist, against diabetic nephropathy in OLETF rats

    European Journal of Pharmacology

    (2002)
  • P.J. Thornalley

    Use of aminoguanidine (Pimagedine) to prevent the formation of advanced glycation end products

    Achieve of Biochemistry & Biophysics

    (2003)
  • P. Vural et al.

    Effects of diabetes mellitus and acute hypertension on plasma nitricoxide and endothelin concentrations in rats

    Clinical & Chemical Acta

    (2002)
  • J.W. Zhang et al.

    Zymographic measurement of gelatinase activity in brain tissue after detergent extraction and affinity-support purification

    Journal of Neuroscience Methods

    (1997)
  • N.E. Cameron et al.

    Inhibitors of advanced glycation end product formation and neurovascular dysfunction in experimental diabetes

    Annual New York Academic Science

    (2005)
  • M.E. Cooper

    Is diabetic nephropathy disappearing from clinical practice?

    Pediatric Diabetes

    (2006)
  • R.C. Correaa et al.

    Plasmatic nitric oxide, but not von Willebrand Factor, is an early marker of endothelial damage, in type 1 diabetes mellitus patients without microvascular complications

    Journal of Diabetes Complications

    (2003)
  • Y. Cui

    The study of different extracts of Radix Rehmannia glutinosa on the HPLC fingerprint

    Journal of Henan College of TCM (Chinese)

    (2003)
  • N. Dhaun et al.

    Haemodynamic and renal effects of endothelin receptor antagonism in patients with chronic kidney disease

    Nephrology Dialysis & Transplantation

    (2007)
  • M. Felx et al.

    Endothelin-1 (ET-1) promotes MMP-2 and MMP-9 induction involving the transcription factor NF-kappaB in human osteosarcoma

    Clinical Science (London)

    (2006)
  • S.Y. Han et al.

    An imbalance between matrix metalloproteinase-2 and tissue inhibitor of matrix metalloproteinase-2 contributes to the development of early diabetic nephropathy

    Nephrology Dialysis & Transplantation

    (2006)
  • H.B. He et al.

    CPU0213, a novel endothelin receptor antagonist, ameliorates septic renal lesion by suppressing ET system and NF-kappaB in rats

    Acta Pharmacological Sinica

    (2006)
  • H. He et al.

    Protective effect of Liuwei Dihuang decoction on early diabetic nephropathy induced by streptozotocin via modulating ET-ROS axis and matrix metalloproteinase activity in rats

    Journal of Pharmacy Pharmacology

    (2007)
  • K.A. Jandeleit-Dahm et al.

    Advanced glycation end products in diabetes-associated atherosclerosis and renal disease: interventional studies

    Annual New York Academic Science

    (2005)
  • Cited by (48)

    • Clinical efficacies, underlying mechanisms and molecular targets of Chinese medicines for diabetic nephropathy treatment and management

      2021, Acta Pharmaceutica Sinica B
      Citation Excerpt :

      Thus, inhibiting ROS generation and ET-1 activation has the potential as a strategy for DN management. In a study, a modified TCM prescription Liuwei-Dihuang Decoction (56.8, 107.8, and 154.7 mg/kg BW, daily, 4 weeks), namely Rehmannia Complex without Fructus Corni, improved STZ-induced early-stage DN in Sprague–Dawley rats (SD-rats) with reductions in 24-h urinary albumin, SCr, and BUN73. In the renal cortex, reduced activities of SOD and GPX, enlarged contents of MDA and ROS, activated activity of ET-1 and augmented expression of ETAR were reversed by ethanol extract of Rehmannia Complex, indicating the potential of Rehmannia Complex to attenuate DN by reducing oxidative stress in the kidney targeting ET-1/ROS signaling pathway73.

    • Naringenin ameliorates daunorubicin induced nephrotoxicity by mitigating AT1R, ERK1/2-NFκB p65 mediated inflammation

      2015, International Immunopharmacology
      Citation Excerpt :

      Activation of the ET receptor type A (ETAR) and ET receptor type B (ETBR) promotes oxidative stress and a compromised free radical scavenging ability [4]. In turn, an increased ROS stimulates the mitogen activated protein kinase (MAPK) pathway and promotes upregulation of ET receptors [8]. Nuclear factor kappa (NFκ)B is a transcriptional factor that regulates many genes involved in immune and inflammatory responses.

    • Plant Extracts and Alkaloids: Prevention of Diabetic Nephropathy

      2013, Bioactive Food as Dietary Interventions for Diabetes
    • Plant Extracts and Alkaloids: Prevention of Diabetic Nephropathy

      2012, Bioactive Food as Dietary Interventions for Diabetes: Bioactive Foods in Chronic Disease States
    • Metabonomic analysis of the therapeutic effect of Zhibai Dihuang Pill in treatment of streptozotocin-induced diabetic nephropathy

      2012, Journal of Ethnopharmacology
      Citation Excerpt :

      ZDP was firstly included in ‘Jingyuequanshu’ by Jingyue Zhang (1563–1640), in which ZDP is usually used for the treatment of kidney deficiency in China. Recently, animal experiments revealed its protective effect on renal injuries of diabetic nephropathy (DN) animal models (Yokozawa et al., 2004; Liu et al., 2008). Clinical studies also reported that ZDP exhibited potentials in the treatment of DN patients (Song et al., 2004; He et al., 2007).

    View all citing articles on Scopus
    View full text